Sanofar Abdeen

616 total citations
15 papers, 218 citations indexed

About

Sanofar Abdeen is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Sanofar Abdeen has authored 15 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Sanofar Abdeen's work include Heat shock proteins research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Sanofar Abdeen is often cited by papers focused on Heat shock proteins research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Sanofar Abdeen collaborates with scholars based in United States and France. Sanofar Abdeen's co-authors include Steven M. Johnson, Eli Chapman, Nilshad Salim, Andrew L. Feig, Anne‐Marie Ray, Corey M. Summers, Quyen Q. Hoang, Yangshin Park, Peter G. Schultz and Andrew J. Ambrose and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Sanofar Abdeen

13 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanofar Abdeen United States 8 153 43 42 41 25 15 218
Janhavi Bhandari United States 7 154 1.0× 44 1.0× 44 1.0× 22 0.5× 24 1.0× 17 301
Anna Modrak‐Wójcik Poland 10 191 1.2× 32 0.7× 20 0.5× 25 0.6× 13 0.5× 13 259
Meagan Belcher Dufrisne United States 9 154 1.0× 24 0.6× 16 0.4× 45 1.1× 23 0.9× 13 273
David M. Dranow United States 11 125 0.8× 25 0.6× 16 0.4× 14 0.3× 15 0.6× 28 200
Nikola Kostlánová Czechia 5 232 1.5× 26 0.6× 33 0.8× 100 2.4× 68 2.7× 5 332
Andrey V. Aralov Russia 14 297 1.9× 31 0.7× 59 1.4× 64 1.6× 19 0.8× 54 465
Yehuda Halfon Israel 9 251 1.6× 55 1.3× 22 0.5× 16 0.4× 12 0.5× 13 332
Francesco Ielasi Belgium 9 213 1.4× 24 0.6× 68 1.6× 19 0.5× 18 0.7× 13 333
Esteban Erben Germany 13 284 1.9× 18 0.4× 23 0.5× 15 0.4× 65 2.6× 23 498
Rodrigue Marquant France 8 132 0.9× 17 0.4× 30 0.7× 20 0.5× 19 0.8× 16 204

Countries citing papers authored by Sanofar Abdeen

Since Specialization
Citations

This map shows the geographic impact of Sanofar Abdeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanofar Abdeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanofar Abdeen more than expected).

Fields of papers citing papers by Sanofar Abdeen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanofar Abdeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanofar Abdeen. The network helps show where Sanofar Abdeen may publish in the future.

Co-authorship network of co-authors of Sanofar Abdeen

This figure shows the co-authorship network connecting the top 25 collaborators of Sanofar Abdeen. A scholar is included among the top collaborators of Sanofar Abdeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanofar Abdeen. Sanofar Abdeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shank-Retzlaff, Mary, et al.. (2024). Capillary mediated vitrification is a novel technique that enables storage of antibody critical reagents at ambient temperature: Impact on binding, structure, and laboratory sustainability. Journal of Pharmaceutical and Biomedical Analysis. 251. 116409–116409. 1 indexed citations
2.
Tillman, Erik J., Sanofar Abdeen, Derrick E. Johnson, et al.. (2023). Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin. Journal of Pharmaceutical and Biomedical Analysis. 232. 115402–115402. 6 indexed citations
4.
Johnson, Derrick E., et al.. (2021). Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain. Scientific Reports. 11(1). 15467–15467. 5 indexed citations
5.
Ray, Anne‐Marie, Nilshad Salim, Sanofar Abdeen, et al.. (2021). Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. Bioorganic & Medicinal Chemistry. 40. 116129–116129. 12 indexed citations
6.
Martinez, Michael J., Guangli Wang, Tohti Amet, et al.. (2021). FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein. New Biotechnology. 62. 79–85. 7 indexed citations
7.
Abdeen, Sanofar, et al.. (2021). Generation of Affinity Purified Antibody Reagents for Specific Determination of Efruxifermin in Biological Matrices. Journal of the Endocrine Society. 5(Supplement_1). A288–A288. 1 indexed citations
8.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2019). HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. PMC. 1 indexed citations
9.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2019). HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. Bioorganic & Medicinal Chemistry Letters. 29(9). 1106–1112. 22 indexed citations
10.
Abdeen, Sanofar, Yulia Ovechkina, Anne‐Marie Ray, et al.. (2019). Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections. Bioorganic & Medicinal Chemistry Letters. 29(13). 1665–1672. 14 indexed citations
11.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2018). Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus. Journal of Medicinal Chemistry. 61(23). 10651–10664. 26 indexed citations
12.
Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2018). Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA). Journal of Medicinal Chemistry. 61(16). 7345–7357. 38 indexed citations
13.
Abdeen, Sanofar, Nilshad Salim, Najiba Mammadova, et al.. (2016). GroEL/ES inhibitors as potential antibiotics. Bioorganic & Medicinal Chemistry Letters. 26(13). 3127–3134. 34 indexed citations
14.
Abdeen, Sanofar, Nilshad Salim, Najiba Mammadova, et al.. (2016). Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness. Bioorganic & Medicinal Chemistry Letters. 26(21). 5247–5253. 25 indexed citations
15.
Abdeen, Sanofar, et al.. (2010). Peptide Inhibitors Targeting Clostridium difficile Toxins A and B. ACS Chemical Biology. 5(12). 1097–1103. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026